These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 7139121

  • 21. GM 58/8: a monoclonal antibody that identifies a new lineage-specific determinant expressed by myeloid progenitors (CFU-GM) and their progeny.
    Das Gupta A, Brice M, Yokochi T, Papayannopoulou T, Stamatoyannopoulos G.
    Br J Haematol; 1984 Sep; 58(1):147-58. PubMed ID: 6205677
    [Abstract] [Full Text] [Related]

  • 22. Positive stem cell selection--basic science.
    Civin CI, Strauss LC, Fackler MJ, Trischmann TM, Wiley JM, Loken MR.
    Prog Clin Biol Res; 1990 Sep; 333():387-401; discussion 402. PubMed ID: 1689854
    [Abstract] [Full Text] [Related]

  • 23. Selective cytotoxicity of murine monoclonal antibody LAM2 against human small-cell carcinoma in the presence of human complement: possible use for in vitro elimination of tumor cells from bone marrow.
    Stahel RA, Mabry M, Sabbath K, Speak JA, Bernal SD.
    Int J Cancer; 1985 May 15; 35(5):587-92. PubMed ID: 2987136
    [Abstract] [Full Text] [Related]

  • 24. Monoclonal antibodies detecting antigenic determinants with restricted expression on erythroid cells: from the erythroid committed progenitor level to the mature erythroblast.
    Yokochi T, Brice M, Rabinovitch PS, Papayannopoulou T, Stamatoyannopoulos G.
    Blood; 1984 Jun 15; 63(6):1376-84. PubMed ID: 6202344
    [Abstract] [Full Text] [Related]

  • 25. Immunologic selection of hemopoietic precursor cells utilizing antibody-mediated plate binding ("panning").
    Greenberg PL, Baker S, Link M, Minowada J.
    Blood; 1985 Jan 15; 65(1):190-7. PubMed ID: 3855263
    [Abstract] [Full Text] [Related]

  • 26. Human T-cell antigens defined by monoclonal antibodies. Absence of T65 on committed myeloid and erythroid progenitors.
    Taetle R, Royston I.
    Blood; 1980 Nov 15; 56(5):943-6. PubMed ID: 6968603
    [Abstract] [Full Text] [Related]

  • 27. Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors.
    Andrews RG, Singer JW, Bernstein ID.
    Blood; 1986 Mar 15; 67(3):842-5. PubMed ID: 3947749
    [Abstract] [Full Text] [Related]

  • 28. HLA-class II antigens on human hematopoietic progenitors.
    Busch FW, Langer M, Pawelec G, Ziegler A, Wernet P, Bühring HJ, Meyer P, Müller C.
    Blut; 1987 Mar 15; 54(3):179-88. PubMed ID: 2434163
    [Abstract] [Full Text] [Related]

  • 29. Distribution of a hematopoietic-specific differentiation antigen of K562 cells in the human myeloid and lymphoid cell lineages.
    Clarke BJ, Liao SK, Leeds C, Soamboonsrup P, Neame PB.
    Cancer Res; 1987 Aug 15; 47(16):4254-9. PubMed ID: 3475169
    [Abstract] [Full Text] [Related]

  • 30. A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells.
    Griffin JD, Linch D, Sabbath K, Larcom P, Schlossman SF.
    Leuk Res; 1984 Aug 15; 8(4):521-34. PubMed ID: 6590930
    [Abstract] [Full Text] [Related]

  • 31. Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination.
    Lemoli RM, Gasparetto C, Scheinberg DA, Moore MA, Clarkson BD, Gulati SC.
    Blood; 1991 Apr 15; 77(8):1829-36. PubMed ID: 2015406
    [Abstract] [Full Text] [Related]

  • 32. The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitors.
    Bühring HJ, Simmons PJ, Pudney M, Müller R, Jarrossay D, van Agthoven A, Willheim M, Brugger W, Valent P, Kanz L.
    Blood; 1999 Oct 01; 94(7):2343-56. PubMed ID: 10498606
    [Abstract] [Full Text] [Related]

  • 33. Monoclonal antibodies raised against K562 cells reacted with human haematopoietic pluripotent stem cells.
    Kubota Y, Tanaka T, Irino S.
    Leuk Res; 1991 Oct 01; 15(4):195-204. PubMed ID: 2030600
    [Abstract] [Full Text] [Related]

  • 34. A novel surface marker (B203.13) of human haemopoietic progenitors, preferentially expressed along the B and myeloid lineages.
    Zamai L, Vitale M, Bennett IM, Croce CM, Perussia B.
    Br J Haematol; 1998 Sep 01; 102(4):965-75. PubMed ID: 9734647
    [Abstract] [Full Text] [Related]

  • 35. An immunotoxin with therapeutic potential in T cell leukemia: WT1-ricin A.
    Myers CD, Thorpe PE, Ross WC, Cumber AJ, Katz FE, Tax W, Greaves MF.
    Blood; 1984 May 01; 63(5):1178-85. PubMed ID: 6370334
    [Abstract] [Full Text] [Related]

  • 36. The reproducibility of acute lymphoblastic leukemia phenotype determinations: evaluation of monoclonal antibody and conventional hematopoietic markers.
    Sobol RE, Mick R, LeBien TW, Ozer H, Minowada J, Anderson K, Ellison RR, Cuttner J, Morrison A, Richards F.
    Leuk Res; 1986 May 01; 10(5):481-5. PubMed ID: 2940420
    [Abstract] [Full Text] [Related]

  • 37. Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro.
    Song H, Vita M, Sallam H, Tehranchi R, Nilsson C, Sidén A, Hassan Z.
    Cancer Chemother Pharmacol; 2007 Nov 01; 60(6):841-9. PubMed ID: 17318617
    [Abstract] [Full Text] [Related]

  • 38. Effect of specific anti-human leukaemia immunotoxins on the colony formation by human haematopoietic progenitors and by human leukaemia cells.
    Tebbi CK, Chervinsky D, Seon BK.
    Clin Exp Immunol; 1985 Jun 01; 60(3):496-500. PubMed ID: 3874727
    [Abstract] [Full Text] [Related]

  • 39. Reactivity profiles of leukemic myeloblasts with monoclonal antibodies directed to sialosyl-Le(x) and other lacto-series type 2 chain antigens:absence of reactivity with normal hematopoietic progenitor cells.
    Muroi K, Suda T, Nojiri H, Ema H, Amemiya Y, Miura Y, Nakauchi H, Singhal A, Hakomori S.
    Blood; 1992 Feb 01; 79(3):713-9. PubMed ID: 1370643
    [Abstract] [Full Text] [Related]

  • 40. Antigenic phenotype of chronic granulocytic leukaemia progenitor cells in chronic phase and in blastic transformation characterized by means of monoclonal antibodies.
    Robak T.
    Arch Immunol Ther Exp (Warsz); 1988 Feb 01; 36(4):471-85. PubMed ID: 3074744
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.